Volume 75, no. 11, p. 5421-5424, 2001. We were informed that three patients (referred to as 19, 26, and 29) had their treatment modified between inclusion and the subsequent plasma collection: a nonnucleoside reverse transcriptase inhibitor Efavirenz (EFV) had been added to their regiment. Thus, for two of them the nonimmunoglobulin inhibitory activity reported is related to EFV.
. 2004 Oct;78(20):11450. doi: 10.1128/JVI.78.20.11450.2004
Immunoglobulin G (IgG) and IgA, but also Nonantibody Factors, Account for In Vitro Neutralization of Human Immunodeficiency Virus (HIV) Type 1 Primary Isolates by Serum and Plasma of HIV-Infected Patients
Renaud Burrer
1, Dominique Salmon-Ceron
1, Sophie Richert
1, Gianfranco Pancino
1, Gabriella Spiridon
1, Sandrine Haessig
1, Virginie Roques
1, Francoise Barre-Sinoussi
1, Anne-Marie Aubertin
1, Christiane Moog
1
Renaud Burrer
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Renaud Burrer
Dominique Salmon-Ceron
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Dominique Salmon-Ceron
Sophie Richert
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Sophie Richert
Gianfranco Pancino
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Gianfranco Pancino
Gabriella Spiridon
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Gabriella Spiridon
Sandrine Haessig
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Sandrine Haessig
Virginie Roques
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Virginie Roques
Francoise Barre-Sinoussi
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Francoise Barre-Sinoussi
Anne-Marie Aubertin
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Anne-Marie Aubertin
Christiane Moog
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
Find articles by Christiane Moog
1INSERM U544, Institut de Virologie, 67000 Strasbourg, and Maladies Infectieuses, Hospital Cochin, and Institut Pasteur, Paris, France
PMCID: PMC521862
This corrects the article "Immunoglobulin G (IgG) and IgA, but also Nonantibody Factors, Account for In Vitro Neutralization of Human Immunodeficiency Virus (HIV) Type 1 Primary Isolates by Serum and Plasma of HIV-Infected Patients" in volume 75 on page 5421.